Captrust Financial Advisors Kala Pharmaceuticals, Inc. Transaction History

Captrust Financial Advisors

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$1.16 - $2.74 $418 - $989	-361 Closed	0 $0
Q3 2021 Nov 16, 2021	SELL	$2.62 - $5.43 $167 - $347	-64 Reduced 15.06%	361 $1,000
Q2 2021 Aug 16, 2021	SELL	$5.06 - $8.15 $4,047 - $6,520	-800 Reduced 65.31%	425 $2,000
Q1 2021 May 17, 2021	BUY	$6.24 - $9.58 $7,644 - $11,735	1,225 New	1,225 $8,000

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $9.82M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.